Tag Archives: United States

Protecting Canadians from Excessive Drug Prices – Consultation Questions

The Organization for Economic Co-operation and Development (OECD) has produced ample evidence showing the correlation between price controls and R&D spending. We know that the more downward pressure on prices, the less R&D done in that country. In Canada, drug prices are set by a  non-elected federal body called the Patented Medicine Prices Review Board

Canada is Shortchanging the U.S. in Pharmaceutical Research and Development

President Trump recently asked CEOs of major research-based pharmaceutical manufacturers to increase research and development of new medicines, and add jobs in America. Given the fact that more is already spent on pharmaceutical research and development (R&D) in the United States than anywhere else in the world, this presents a serious challenge for pharmaceutical companies.

Medicaid in a New Era – Presentation by Robert Freeman

Medicaid in a new era – Robert Freeman from PFCD on Vimeo. Watch Robert Freeman’s presentation at ‘Medicaid in a new era:  proven solutions that enhance quality and reduce costs.”  This event was co-hosted by the Partnership to Fight Chronic Disease and UnitedHealthcare. Robert Freeman was presenting the results of a Cameron Institute research paper

The Effectiveness of Disease Management Programs in the Medicaid Population

Robert Freeman, Ph.D., Kristina M. Lybecker, Ph.D., D. Wayne Taylor, Ph.D., F.CIM Executive Summary In the midst of rising health care expenditures, increasingly limited health care budgets and economic uncertainty, the efficient use of government funds and other resources is of the utmost importance.  In March 2010, the Patient Protection and Affordable Care Act (ACA)